Dengue seroprevalence of healthy adults in Singapore: Serosurvey among blood donors, 2009

American Journal of Tropical Medicine and Hygiene

Volumn 93, Issue 1, 2015, Pages 40-45

  Low, Swee Ling ^a   Lam, Sally ^b   Wong, Wing Yan ^a   Teo, Diana ^b   Ng, Lee Ching ^a   Tan, Li Kiang ^a  

^a NATIONAL ENVIRONMENT AGENCY   (Singapore)

^b HEALTH SCIENCES AUTHORITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PLAQUE REDUCTION NEUTRALIZATION TEST; SCREENING TEST; SERODIAGNOSIS; SEROPREVALENCE; SEROTYPE; SINGAPORE; VIRUS STRAIN; YOUNG ADULT; AGE DISTRIBUTION; DENGUE VIRUS; IMMUNOLOGY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLOOD DONORS; CROSS-SECTIONAL STUDIES; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SINGAPORE; YOUNG ADULT;

EID: 84937010552     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.14-0671     Document Type: Article

References (41)

1. World Health Organization, 2012. Global Strategy for Dengue Prevention and Control. Available at: http://www.who.int/denguecontrol/9789241504034/en. Accessed January 21, 2013.
2. World Health Organization, 2012. Dengue and Severe Dengue. Fact sheet No. 117. Available at: http://www.who.int/mediacentre/factsheets/fs117/en/. Accessed January 21, 2013.
3. Murray NE, Quam MB, Wilder-Smith A, 2013. Epidemiology of dengue: past, present and future prospects. Clin Epidemiol 5: 299-309.
4. Wichmann O, Yoon IK, Vong S, Limkittikul K, Gibbons RV, Mammen MP, Ly S, Buchy P, Sirivichayakul C, Buathong R, Huy R, Letson GW, Sabchareon A, 2011. Dengue in Thailand and Cambodia: an assessment of the degree of underrecognized disease burden based on reported cases. PLoS Negl Trop Dis 5: e996.
5. Standish K, Kuan G, Aviles W, Balmaseda A, Harris E, 2010. High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data. PLoS Negl Trop Dis 4: e633.
6. Burke DS, Nisalak A, Johnson DE, Scott RM, 1988. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38: 172-180.
7. Yap G, Li C, Mutalib A, Lai YL, Ng LC, 2013. High rates of inapparent dengue in older adults in Singapore. Am J Trop Med Hyg 88: 1065-1069.
8. Goh KT, Yamazaki S, 1987. Serological survey on dengue virus infection in Singapore. Trans R Soc Trop Med Hyg 81: 687-689.
9. Goh KT, 1995. Changing epidemiology of dengue in Singapore. Lancet 346: 1098.
10. Koh BK, Ng LC, Kita Y, Tang CS, Ang LW, Wong KY, James L, Goh KT, 2008. The 2005 dengue epidemic in Singapore: epidemiology, prevention and control. Ann Acad Med Singapore 37: 538-545.
11. Ministry of Health, Singapore, 2005. Communicable Diseases Surveillance in Singapore 2005. Singapore: Ministry of Health, 25-47.
12. Ministry of Health, Singapore, 2006. Communicable Diseases Surveillance in Singapore 2006. Singapore: Ministry of Health, 25-43.
13. Ministry of Health, Singapore, 2007. Communicable Diseases Surveillance in Singapore 2007. Singapore: Ministry of Health, 21-43.
14. Ler TS, Ang LW, Yap G, Ng LC, Tai JC, James L, Goh KT, 2011. Epidemiological characteristics of the 2005 and 2007 dengue epidemics in Singapore: similarities and distinctions. Western Pac Surveill Response J 2: 24-29.
15. Committee on Epidemic Diseases, Singapore, 2000. Seroprevalence of dengue virus infection in Singapore. Epidemiol News Bull 26: 30-31.
16. Wilder-Smith A, Yoksan S, Earnest A, Subramaniam R, Paton NI, 2005. Serological evidence for the co-circulation of multiple dengue virus serotypes in Singapore. Epidemiol Infect 133: 667-671.
17. Chow VTK, Lim CS, Phoon MC, Tan HC, 2005. A Seroprevalence survey of dengue virus infection in healthy Singapore University undergraduates by enzyme immunoassay and plaque reduction neutralization test. Dengue Bull 29: 97-105.
18. Yew YW, Ye T, Ang LW, Ng LC, Yap G, James L, Chew SK, Goh KT, 2009. Seroepidemiology of dengue virus infection among adults in Singapore. Ann Acad Med Singapore 38: 667-675.
19. Morens DM, Halstead SB, Repik PM, Putvatana R, Raybourne N, 1985. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 22: 250-254.
20. Russell PK, Nisalak A, Sukhavachana P, Vivona S, 1967. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 99: 285-290.
21. Yew YW, Ye T, Ang LW, Ng LC, Yap G, James L, Chew SK, Goh KT, 2009. Seroepidemiology of dengue virus infection among adults in Singapore. Ann Acad Med Singapore 38: 667-675.
22. Chungue E, Marche G, Plichart R, Boutin JP, Roux J, 1989. Comparison of immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA) and haemagglutination inhibition (HI) test for the detection of dengue antibodies. Prevalence of dengue IgG-ELISA antibodies in Tahiti. Trans R Soc Trop Med Hyg 83: 708-711.
23. McBride WJ, Mullner H, LaBrooy JT, Wronski I, 1998. The 1993 dengue 2 epidemic in north Queensland: a serosurvey and comparison of hemagglutination inhibition with an ELISA. Am J Trop Med Hyg 59: 457-461.
24. Ministry of Health, Singapore, 2004. Communicable Diseases Surveillance in Singapore, 2004. Singapore: Ministry of Health, 27-38.
25. Ministry of Health, Singapore, 2013. Communicable Diseases Surveillance in Singapore, 2013. Singapore: Ministry of Health, 52-65.
26. Ministry of Health, Singapore, 2014. Prevalence of past dengue virus infection among children and adults in Singapore. Epidemiol News Bull 40: 102-106.
27. Thai KT, Nishiura H, Hoang PL, Tran NT, Phan GT, Le HQ, Tran BQ, Nguyen NV, de Vries PJ, 2011. Age-specificity of clinical dengue during primary and secondary infections. PLoS Negl Trop Dis 5: e1180.
28. Malavige GN, Fernando S, Aaskov J, Sivayogan S, Dissanayaka T, Peelawattage M, Dabare M, 2006. Seroprevalence of anti-dengue virus antibodies in children in Colombo District, Sri Lanka. Dengue Bull 30: 68-71.
29. Thai KT, Binh TQ, Giao PT, Phuong HL, Hung le Q, Van Nam N, Nga TT, Groen J, Nagelkerke N, de Vries PJ, 2005. Seroprevalence of dengue antibodies, annual incidence and risk factors among children in southern Vietnam. Trop Med Int Health 10: 379-386.
30. Brunkard JM, Robles Lopez JL, Ramirez J, Cifuentes E, Rothenberg SJ, Hunsperger EA, Moore CG, Brussolo RM, Villarreal NA, Haddad BM, 2007. Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004. Emerg Infect Dis 13: 1477-1483.
31. Balmaseda A, Hammond SN, Tellez Y, Imhoff L, Rodriguez Y, Saborio SI, Mercado JC, Perez L, Videa E, Almanza E, Kuan G, Reyes M, Saenz L, Amador JJ, Harris E, 2006. High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health 11: 935-942.
32. Yamashiro T, Disla M, Petit A, Taveras D, Castro-Bello M, Lora-Orste M, Vardez S, Cesin AJ, Garcia B, Nishizono A, 2004. Seroprevalence of IgG specific for dengue virus among adults and children in Santo Domingo, Dominican Republic. Am J Trop Med Hyg 71: 138-143.
33. Braga C, Luna CF, Martelli CM, de Souza WV, Cordeiro MT, Alexander N, de Albuquerque Mde F, Junior JC, Marques ET, 2010. Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil. Acta Trop 113: 234-240.
34. Muhammad Azami NA, Salleh SA, Neoh HM, Syed Zakaria SZ, Jamal R, 2011. Dengue epidemic in Malaysia: not a predominantly urban disease anymore. BMC Res Notes 4: 216.
35. Lee KS, Lai YL, Lo S, Barkham T, Aw P, Ooi PL, Tai JC, Hibberd M, Johansson P, Khoo SP, Ng LC, 2010. Dengue virus surveillance for early warning, Singapore. Emerg Infect Dis 16: 847-849.
36. Ministry of Health, Singapore, 2012. Review of dengue serotype surveillance programme in Singapore. Epidemiol News Bull 38: 54-62.
37. Schwartz E, Mileguir F, Grossman Z, Mendelson E, 2000. Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers. J Clin Virol 19: 169-173.
38. Cordeiro MT, Braga-Neto U, Nogueira RM, Marques ET Jr, 2009. Reliable classifier to differentiate primary and secondary acute dengue infection based on IgG ELISA. PLoS One 4: e4945.
39. Koh YL, Tan BH, Loh JJ, Ooi EE, Su SY, Hsu LY, 2006. Japanese encephalitis, Singapore. Emerg Infect Dis 12: 525-526.
40. World Health Organization, 2014. World Health Statistics 2014. Available at: http://www.who.int/gho/publications/world-health-statistics/2014/en/. Accessed August 23, 2014.
41. Teo D, Ng LC, Lam S, 2009. Is dengue a threat to the blood supply? Transfus Med 19: 66-77.